Acquisitions6 Mar 2026, 03:46 pm
Alkem Laboratories to Acquire Major Stake in Occlutech Holding AG
AI Summary
Alkem Laboratories Ltd, through its wholly owned subsidiary Alkem Medtech Private Limited, has signed a Share Purchase Agreement to acquire at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG, a company incorporated in Switzerland. This announcement is a continuation of the earlier intimation dated 13th February, 2026, where the Stock Exchanges were informed about Alkem Medtech's intention to acquire a significant stake in Occlutech.
Key Highlights
- Alkem Medtech, a wholly owned subsidiary of Alkem Laboratories, has signed a Share Purchase Agreement with Occlutech Holding AG's selling shareholders.
- The acquisition will result in Alkem Medtech holding at least 51% and up to 55% of Occlutech Holding AG's total issued equity share capital.
- Occlutech Holding AG is a company based in Switzerland.
- This announcement follows an earlier intimation to the Stock Exchanges on 13th February, 2026, regarding Alkem Medtech's intention to acquire a significant stake in Occlutech Holding AG.